Back to search

Finland· FI-REL-REL6990

Insulin Mc Rapitard

A insulins and analogues for injection, intermediate- or long-acting combined with fast-acting product, registered in Finland by Novo Nordisk A/S. The same ATC class is registered in 2 of our 19 countries.

ATC A10AD

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedInsulin Mc RapitardATCA10ADREGISTER NO.FI-REL-REL6990PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Insulin is registered in 2 of 19 countries.

Countries holding a registration under ATC A10AD (insulins and analogues for injection, intermediate- or long-acting combined with fast-acting), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Insulin · ATC A10AD

2 / 19 countries

  • Finlandprice
  • Ireland
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Manufacturer
Novo Nordisk A/S
Country
Finland (FI)
ATC code
A10AD
ATC class
Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dbdff7cf-5367-4610-a2c1-4e1157e56bfa
GET /v1/drugs/dbdff7cf-5367-4610-a2c1-4e1157e56bfa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "40",
  "form": "injektioneste",
  "route": null,
  "ddd_unit": "U",
  "strength": "40 IU/ml",
  "atc_label": "Insuliinisekoitteet",
  "ma_number": "1128",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL6990",
  "authorised_at": "1965-03-03"
}

See everything about Insulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.